Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy

Basic Research in Cardiology

Volumn 98, Issue 4, 2003, Pages 259-266

  Becker, Rüdiger ^a   Haass, Markus ^a   Ick, Dirk ^a   Krueger, Carsten ^a   Bauer, Alexander ^a   Senges Becker, Julia C ^a   Voss, Frederik ^a   Hilbel, Thomas ^a   Niroomand, Feraydoon ^a   Katus, Hugo A ^a   Schoels, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Holter ECG; Idiopathic dilated cardiomyopathy; Nonsustained ventricular tachycardia; Programmed ventricular stimulation; Risk stratification; Ventricular arrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PHENPROCOUMON;

ADULT; AGE; AGED; ARRHYTHMOGENESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART STIMULATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTION AND FORECASTING; PROGNOSIS; PROGRAMMED VENTRICLE STIMULATION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; SURVIVAL; SYNCOPE;

EID: 10744229536     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-003-0398-7     Document Type: Article

References (37)

1. Turitto G, Ahuja RK, Caref EB, El-Sherif N (1994) Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 24: 1523-1528
2. Hoffmann T, Meinertz T, Kasper W et al. (1988) Mode of death in idiopathic dilated cardiomyopathy: A multivariate analysis of prognostic determinants. Am Heart J 116: 1455-1463
3. The SOLVD investigators (1991) Effect of enelapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators. N Engl J Med 325 (5): 293-302
4. Waagstein F, Bristow MR, Swedberg K et al. (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441-1446
5. Holmes J, Kubo SH, Cody RJ, Kligfield P (1985) Arrhythmias in ischemic and noniscemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 55: 146-151
6. Von Oshausen K, Stienen U, Schwarz F et al. (1988) Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 61: 146-151
7. Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124: 1035-1045
8. Bayes De Luna A, Coumel P, Leclercq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117: 151-159
9. Bänsch D, Antz M, Boczor S et al. (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The cardiomyopathy trial (CAT). Circulation 105: 1453-1458
10. Doval HC, Nul DR, Grancelli HO et al. (1996) Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 94 (12): 3198-3203
11. Meinertz T, Hofmann T, Kasper W et al. (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53: 902-907
12. Gradman A, Deedwania P, Cody R et al. (1989) Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 14: 564-570
13. Szabo BM, Van Veldhuisen DJ, Crijns HJ et al. (1994) Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J 15: 928-933
14. Von Olshausen K, Schäfer A, Mehmel HC et al. (1984) Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 51: 195-201
15. Huang SK, Messer JV, Denes P (1983) Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients. Am J Cardiol 51: 507-512
16. Singh SN, Fisher SG, Carson PE, Fletcher RD (1998) Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 32: 942-947
17. Grimm W, Hoffmann J, Menz V et al. (1998) Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 32: 739-745
18. Gossinger HD, Jung M, Wagner L et al. (1990) Prognostic role of inducible ventricular tachycardia in patients with dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. Int J Cardiol 29: 215-220
19. Buxton AE, Marchilinski FE, Waxman HL et al. (1984) Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 53: 1275-1279
20. Sulpizi AM, Friehling TD, Kowey PR (1987) Value of electrophysiologic testing in patients with nonsustained ventricular tachycardia. Am J Cardiol 59: 841-845
21. Kadish A, Schmaltz S, Calkins H, Morady F (1993) Management of nonsustained ventricular tachycardia guided by electrophysiological testing. Pacing Clin Electrophysiol 16: 1037-1050
22. Das SK, Morady F, DiCarlo L et al. (1986) Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 58: 998-1000
23. Kron J, Hart M, Schual-Berke S et al. (1988) Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and holter monitoring in predicting those at risk of sudden death. Chest 93: 85-90
24. Poll DS, Marchlinski FE, Buxton AE, Josephson ME (1986) Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 58: 992-997
25. Stamato NJ, O'Connell JB, Murdock DK et al. (1986) The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to pogrammed electrical stimulation. Am Heart J 112: 505-508
26. Podczeck A, Rudolphi H, Borggrefe M, Breithardt G (1987) Bedeutung der programmierten Ventrikelstimulation bei Patienten mit ventrikulären Salven. Z Kardiol 76: 396-403
27. Gonska BD, Bethge KP, Kreuzer H (1987) Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: Influence of the underlying heart disease on the results of electrophysiologic testing. Clin Cardiol 10: 294-304
28. Stevenson WG, Stevenson LW, Weiss J, Tillisch JH (1988) Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J 116: 1447-1454
29. Gomes JAC, Hariman RI, Kang PS et al. (1984) Programmed electrical stimulation in patients with high-grade ventricular ectopy: Electrophysiologic findings and prognosis for survival. Circulation 70: 43-51
30. Brembilla-Perrot B, Donetti J, De La Chaise AT et al. (1991) Diagnostic value of ventricular stimulation in patients with dilated cardiomyopathy. Am Heart J 121: 1124-1131
31. Meinertz T, Treese N, Kasper W et al. (1985) Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol 56: 337-341
32. Zugck C, Krüger C, Dürr S et al. (2000) Is the six minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 21: 540-549
33. Unverferth DV, Magorien RD, Moeschberger ML et al. (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147-152
34. Grimm W, Glaveris C, Hoffmann J et al. (2000) Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography. Am Heart J 140: 43-51
35. Teerlink JR, Jalaluddin M, Anderson S et al; on behalf of the PROMISE investigators (2000) Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 101: 40-46
36. Knight BP, Goyal R, Pelosi F et al. (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33: 1964-1970
37. Packer M, Bristow MR, Cohn JN et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349-1355